• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

发育不良痣和黑色素瘤。

Dysplastic nevi and melanoma.

机构信息

Genetic Epidemiology Branch/NCI, Executive Plaza South, Room 7004, 6120 Executive Blvd. MSC 7236, Bethesda, MD 20892, USA.

出版信息

Cancer Epidemiol Biomarkers Prev. 2013 Apr;22(4):528-32. doi: 10.1158/1055-9965.EPI-12-1346.

DOI:10.1158/1055-9965.EPI-12-1346
PMID:23549396
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3616416/
Abstract

Dysplastic nevi are described as being on a continuum between common acquired nevi and melanoma because they are morphologically and biologically intermediate between these 2 entities. Since initially being reported as histologic lesions observed in melanoma-prone families, there has been considerable debate about the definition of dysplastic nevi, the histologic and clinical criteria used to define them, and their biologic importance. Their role as precursor lesions for melanoma is not their primary role in their relationship to melanoma because of the rarity of transformation of any individual nevus to a melanoma. Although there is still no single, universally agreed upon histologic or clinical definition or even name for these nevi, dysplastic nevi should be considered important because of their association with an increased risk for melanoma.

摘要

发育不良性痣被描述为介于常见获得性痣和黑色素瘤之间的连续体,因为它们在形态学和生物学上介于这两种实体之间。自从最初被报道为在易患黑色素瘤的家族中观察到的组织学病变以来,关于发育不良性痣的定义、用于定义它们的组织学和临床标准以及它们的生物学重要性一直存在相当大的争议。它们作为黑色素瘤前体病变的作用并不是它们与黑色素瘤关系中的主要作用,因为任何单个痣向黑色素瘤的转化都非常罕见。尽管对于这些痣,仍然没有一个单一的、普遍同意的组织学或临床定义,甚至没有一个通用的名称,但由于它们与黑色素瘤风险增加有关,发育不良性痣仍应被视为重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2419/3616416/549fb773a7e8/nihms445870f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2419/3616416/549fb773a7e8/nihms445870f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2419/3616416/549fb773a7e8/nihms445870f1.jpg

相似文献

1
Dysplastic nevi and melanoma.发育不良痣和黑色素瘤。
Cancer Epidemiol Biomarkers Prev. 2013 Apr;22(4):528-32. doi: 10.1158/1055-9965.EPI-12-1346.
2
Problems with lesions related to the development of malignant melanoma: common nevi, dysplastic nevi, malignant melanoma in situ, and radial growth phase malignant melanoma.与恶性黑色素瘤发生相关的病变问题:普通痣、发育异常痣、原位恶性黑色素瘤和放射状生长期恶性黑色素瘤。
Hum Pathol. 1998 Jan;29(1):8-14. doi: 10.1016/s0046-8177(98)90384-7.
3
The "dysplastic" nevus.“发育异常性”痣。
Clin Dermatol. 2009 Jan-Feb;27(1):103-15. doi: 10.1016/j.clindermatol.2008.09.008.
4
Correlation of clinical pigmentary characteristics with histopathologically-confirmed dysplastic nevi in nonfamilial melanoma patients. Studies of melanocytic nevi IX.非家族性黑色素瘤患者临床色素沉着特征与组织病理学确诊的发育异常痣的相关性。黑素细胞痣的研究IX。
Br J Cancer. 1991 Nov;64(5):943-7. doi: 10.1038/bjc.1991.431.
5
[Dysplastic nevi--precursors of malignant melanoma?].发育异常痣——恶性黑色素瘤的前驱病变?
Lakartidningen. 1987 Aug 19;84(34):2587-9.
6
Histologic correlations with the clinical diagnosis of dysplastic nevus.发育异常痣临床诊断的组织学相关性
Am J Surg Pathol. 1990 Jan;14(1):44-52. doi: 10.1097/00000478-199001000-00005.
7
Melanocytic lesions in a private pathology practice. Comparison of histologic features in different tumor types with particular reference to dysplastic nevi.私人病理诊所中的黑素细胞性病变。不同肿瘤类型组织学特征的比较,特别提及发育异常痣。
APMIS. 1993 Nov;101(11):845-50. doi: 10.1111/j.1699-0463.1993.tb00190.x.
8
Prediction of histologic melanocytic dysplasia from clinical observation.基于临床观察对组织学黑素细胞发育异常的预测。
J Am Acad Dermatol. 1993 Oct;29(4):555-62. doi: 10.1016/0190-9622(93)70221-e.
9
A relation between childhood sun exposure and dysplastic nevus syndrome among patients with nonfamilial melanoma.非家族性黑色素瘤患者中儿童期阳光暴露与发育异常痣综合征之间的关系。
Epidemiology. 1991 May;2(3):210-4. doi: 10.1097/00001648-199105000-00009.
10
The dysplastic nevus: recognition and management.发育异常痣:识别与处理
Plast Reconstr Surg. 1988 Feb;81(2):280-9. doi: 10.1097/00006534-198802000-00027.

引用本文的文献

1
Genetic Landscape of Familial Melanoma.家族性黑色素瘤的遗传图谱
Genes (Basel). 2025 Jul 23;16(8):857. doi: 10.3390/genes16080857.
2
METTL9 as a protein biomarker predicts the prognosis and immunotherapy response of skin-cutaneous melanoma.METTL9作为一种蛋白质生物标志物可预测皮肤黑色素瘤的预后和免疫治疗反应。
Ann Med Surg (Lond). 2025 Jun 13;87(8):4918-4925. doi: 10.1097/MS9.0000000000003480. eCollection 2025 Aug.
3
A Comparison of Skin Lesions' Diagnoses Between AI-Based Image Classification, an Expert Dermatologist, and a Non-Expert.

本文引用的文献

1
Dysplastic nevi.发育不良痣。
Dermatol Clin. 2012 Jul;30(3):389-404. doi: 10.1016/j.det.2012.04.004. Epub 2012 Jun 8.
2
The dysplastic nevus: from historical perspective to management in the modern era: part I. Historical, histologic, and clinical aspects.发育不良性痣:从历史角度到现代时代的管理:第一部分。历史、组织学和临床方面。
J Am Acad Dermatol. 2012 Jul;67(1):1.e1-16; quiz 17-8. doi: 10.1016/j.jaad.2012.02.047.
3
Melanoma genetics: recent findings take us beyond well-traveled pathways.黑色素瘤遗传学:最新研究发现超越了已知途径。
基于人工智能的图像分类、皮肤科专家和非专家对皮肤病变诊断的比较
Diagnostics (Basel). 2025 Apr 28;15(9):1115. doi: 10.3390/diagnostics15091115.
4
PPAR-γ in Melanoma and Immune Cells: Insights into Disease Pathogenesis and Therapeutic Implications.黑色素瘤与免疫细胞中的过氧化物酶体增殖物激活受体γ:对疾病发病机制及治疗意义的见解
Cells. 2025 Apr 2;14(7):534. doi: 10.3390/cells14070534.
5
Association Between Poor Lifestyle Habits and Cutaneous Melanoma Risk: A Mendelian Randomization Study.不良生活习惯与皮肤黑色素瘤风险之间的关联:一项孟德尔随机化研究。
Clin Cosmet Investig Dermatol. 2025 Mar 21;18:687-697. doi: 10.2147/CCID.S506547. eCollection 2025.
6
Uncovering Barriers to the Diagnosis and Treatment of Metastatic Melanoma: A Case Report.揭示转移性黑色素瘤诊断与治疗的障碍:一例报告
Cureus. 2024 Dec 14;16(12):e75716. doi: 10.7759/cureus.75716. eCollection 2024 Dec.
7
Frequency of BRAF Mutations in Dysplastic Nevi, Lentigo Maligna, and Melanoma In Situ.发育异常痣、恶性雀斑样痣及原位黑色素瘤中BRAF突变的频率
J Clin Med. 2024 Aug 15;13(16):4799. doi: 10.3390/jcm13164799.
8
Tracing cancer evolution and heterogeneity using Hi-C.利用 Hi-C 技术追踪癌症进化和异质性。
Nat Commun. 2023 Nov 6;14(1):7111. doi: 10.1038/s41467-023-42651-2.
9
Incidence of different types of cancer in the follow-up period after primary diagnosis and treatment of melanoma. Single-centre 4-year follow-up on a population of 709 patients.黑色素瘤初次诊断和治疗后随访期间不同类型癌症的发病率。对709名患者群体进行的单中心4年随访。
Postepy Dermatol Alergol. 2023 Jun;40(3):416-420. doi: 10.5114/ada.2023.127545. Epub 2023 Jun 21.
10
Catching Cancer Early: The Importance of Dermato-Oncology Screening.早期发现癌症:皮肤肿瘤学筛查的重要性。
Cancers (Basel). 2023 Jun 6;15(12):3066. doi: 10.3390/cancers15123066.
J Invest Dermatol. 2012 Jul;132(7):1763-74. doi: 10.1038/jid.2012.75. Epub 2012 Apr 5.
4
The impact of physician screening on melanoma detection.医生筛查对黑色素瘤检测的影响。
Arch Dermatol. 2011 Nov;147(11):1269-75. doi: 10.1001/archdermatol.2011.181. Epub 2011 Jul 18.
5
Benefits of total body photography and digital dermatoscopy ("two-step method of digital follow-up") in the early diagnosis of melanoma in patients at high risk for melanoma.全身摄影和数字皮肤镜检查(“数字随访两步法”)在高风险黑色素瘤患者早期诊断黑色素瘤中的益处。
J Am Acad Dermatol. 2012 Jul;67(1):e17-27. doi: 10.1016/j.jaad.2011.04.008. Epub 2011 Jun 16.
6
Swedish CDKN2A mutation carriers do not present the atypical mole syndrome phenotype.瑞典 CDKN2A 突变携带者不呈现非典型痣综合征表型。
Melanoma Res. 2010 Aug;20(4):266-72. doi: 10.1097/CMR.0b013e3283341339.
7
Dysplastic naevi: an update.发育不良痣:更新。
Histopathology. 2010 Jan;56(1):112-20. doi: 10.1111/j.1365-2559.2009.03450.x.
8
Multiple pigmentation gene polymorphisms account for a substantial proportion of risk of cutaneous malignant melanoma.多种色素基因多态性占皮肤恶性黑色素瘤风险的很大一部分。
J Invest Dermatol. 2010 Feb;130(2):520-8. doi: 10.1038/jid.2009.258. Epub 2009 Aug 27.
9
Genome-wide association study identifies variants at 9p21 and 22q13 associated with development of cutaneous nevi.全基因组关联研究确定了与皮肤痣发生相关的9p21和22q13区域的变异。
Nat Genet. 2009 Aug;41(8):915-9. doi: 10.1038/ng.410. Epub 2009 Jul 5.
10
Melanoma epidemiology.黑色素瘤流行病学
Hematol Oncol Clin North Am. 2009 Jun;23(3):383-95, vii. doi: 10.1016/j.hoc.2009.03.010.